Effects of Cilazapril on Vascular Structure and Function in Essential Hypertension
- 1 March 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (3) , 371-376
- https://doi.org/10.1161/01.hyp.27.3.371
Abstract
Abstract Hypertension is associated with an altered design of resistance vessels and decreased endothelium-dependent vasodilator response to acetylcholine. A role of angiotensin II in both defects is suggested by animal experiments in which angiotensin-converting enzyme inhibition reverted structural and functional changes. We investigated the effects of 20 weeks of therapy with the angiotensin-converting enzyme inhibitor cilazapril (5 mg twice daily) on the endothelium-dependent response to brachial artery infusions of acetylcholine and the endothelium-independent vascular relaxation after sodium nitroprusside in 22 subjects with mild to moderate essential hypertension. In addition, we measured minimal forearm vascular resistance (ratio of mean arterial pressure and forearm blood flow after heating, ischemia, and ischemic exercise) as an indirect estimate of vascular structure. Cilazapril decreased blood pressure (151±14/99±7 mm Hg during placebo to 138±17/89±8 mm Hg after cilazapril treatment, P <.01) and baseline (42.2±12.6 to 37.1±10.6 U, P <.05) and minimal (3.0±1.1 to 2.4±0.7 U, 15.9±20.2%; P <.05) forearm vascular resistances. The change in minimal forearm vascular resistance was unrelated to age, duration of hypertension, or changes in blood pressure. Sodium nitroprusside increased forearm blood flow from 2.6±1.0 to 11.4±5.9 mL/min per 100 mL and acetylcholine to 21.5±17.8. Both responses did not change after cilazapril. The data provide indirect evidence that cilazapril therapy may improve vascular structure in human hypertension. The lack of relationship between vascular and blood pressure changes would be compatible with experimental evidence supporting a role for angiotensin II in the development and regression of vascular changes, but this needs further study. Therapy with cilazapril for 20 weeks, like other antihypertensive therapy, does not seem to influence endothelial vasodilator function in humans to a significant degree.Keywords
This publication has 43 references indexed in Scilit:
- Effect of captopril and enalapril on endothelial function in hypertensive patients.Hypertension, 1994
- Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients.Hypertension, 1992
- Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy.Hypertension, 1992
- Are vascular abnormalities a primary cause or secondary consequence of hypertension?Hypertension, 1991
- Antihypertensive Duration of Action of Cilazapril in Patients with Mild to Moderate Essential HypertensionDrugs, 1991
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.Hypertension, 1987
- Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.Hypertension, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980